Obsidian Therapeutics
Published indications, not live orders. Newest first; matching records grouped.
Latest observed . Availability is not verified.
Buyers 0
No published buyers.
Sellers 5
| Date | Price / size | Broker | Terms |
|---|---|---|---|
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesListed under past four days' inventory with supply available. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesListed as supply in the past four days' inventory; terms not provided. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesSupply listed in past four days' inventory; terms not provided. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesSupply listed in past four days inventory. | |
| UnpricedSize undisclosed | Setter Capital | Not specifiedNotesListed in the latest daily inventory with supply available; block details were not provided. |
Financing history
| Round | Date | Raised | Pre-money | Post-money | Price / share | Investors |
|---|---|---|---|---|---|---|
| Reverse Merger | Aug 3, 2026 | — | — | — | — | Galera Therapeutics
|
| PIPE | Aug 3, 2026 | $350M | — | — | — | Atlas Venture, Balyasny Asset Management +18
|
| Series C | Mar 27, 2024 | $160.5M | $339.5M | $500M | $1.90 | — |
| Series B | Sep 9, 2021 | — | — | — | — | — |
| Series A | Dec 6, 2017 | — | — | — | — | — |
| Equity-Based Accelerator | Apr 15, 2017 | — | — | — | — | — |
| Non-Equity Accelerator | Undated | — | — | — | — | — |
PitchBook cached data. Investor participation is historical, not proof of current ownership. Lead labels appear only when reported. Missing details remain unspecified.
Investor participation · 21 names in the returned rounds
| Investor | Reported rounds |
|---|---|
| Atlas Venture | PIPE · 2026-08-03 |
| Balyasny Asset Management | PIPE · 2026-08-03 |
| Caligan Partners | PIPE · 2026-08-03 |
| Deep Track Capital | PIPE · 2026-08-03 |
| Eventide Asset Management | PIPE · 2026-08-03 |
| Foresite Capital | PIPE · 2026-08-03 |
| Galera Therapeutics | Reverse Merger · 2026-08-03 |
| Janus Henderson Investors | PIPE · 2026-08-03 |
| Logos Capital | PIPE · 2026-08-03 |
| Nantahala Capital Management | PIPE · 2026-08-03 |
| Novo Holdings | PIPE · 2026-08-03 |
| Octagon Capital Investments | PIPE · 2026-08-03 |
| Paradigm BioCapital | PIPE · 2026-08-03 |
| Pivotal bioVenture Partners | PIPE · 2026-08-03 |
| RA Capital Management | PIPE · 2026-08-03 |
| Redmile Group | PIPE · 2026-08-03 |
| RTW Investments | PIPE · 2026-08-03 |
| Spruce Street Capital | PIPE · 2026-08-03 |
| TCG Crossover Management | PIPE · 2026-08-03 |
| Trails Edge Capital Partners | PIPE · 2026-08-03 |
| Wellington Management | PIPE · 2026-08-03 |
Cached deal details · 7 rounds
| Round / date | Type / status | Investors | Exiting investors | Stored on |
|---|---|---|---|---|
| Reverse Merger2026-08-03 | Reverse MergerCompleted | Galera Therapeutics
| Not specified | 2026-10-15 |
| PIPE2026-08-03 | PIPECompleted | Atlas Venture, Balyasny Asset Management +18
| Not specified | 2026-10-15 |
| Series C2024-03-27 | Later Stage VCCompleted | — | Not specified | 2026-10-15 |
| Series B2021-09-09 | Not specifiedStatus not specified | — | Not specified | 2026-10-15 |
| Series A2017-12-06 | Not specifiedStatus not specified | — | Not specified | 2026-10-15 |
| Equity-Based Accelerator2017-04-15 | Not specifiedStatus not specified | — | Not specified | 2026-10-15 |
| Non-Equity AcceleratorUndated | Not specifiedStatus not specified | — | Not specified | 2026-10-15 |
Stored on is the local round-record date, not the last time PitchBook verified it. No new provider lookups run when this page is opened.
Suggest a correction · Active members can send a private report for admin review.